RESEARCH NEWS 2011-11-22 Research News Beacons for possible future dementia often go unnoticed because seeing them requires imaging technology only available in specialized research centers. The tide may soon turn, though. New developments in amyloid imaging with F18-labeled posi
CONFERENCE COVERAGE 2011-11-22 Conference Coverage Regular visitors to Alzforum will be familiar with the use of positron emission tomography, magnetic resonance imaging, and cerebrospinal fluid measurements as markers for Alzheimer’s disease (AD). But these three are not the only AD b
Vanderbilt UniversityNashville, United States
PAPER Martin LJ, Chen K, Liu Z
J Neurosci. 2005 Jul 6;25(27):6449-59. PubMed: 16000635
PAPER Levenson JM, Roth TL, Lubin FD, Miller CA, Huang IC, Desai P, Malone LM, Sweatt JD
J Biol Chem. 2006 Jun 9;281(23):15763-73. PubMed: 16606618
PAPER Kondo T, Bobek MP, Kuick R, Lamb B, Zhu X, Narayan A, Bourc'his D, Viegas-Péquignot E, Ehrlich M, Hanash SM
Hum Mol Genet. 2000 Mar 1;9(4):597-604. PubMed: 10699183
Health4Brands ChelseaNew York, United States
AstraZenecaSödertälje, Sweden
PAPER Atakhanov Sh, Adzhimollaev TA, Zimina RV, Nikolaeva LF
Ter Arkh. 1978;50(8):20-4. PubMed: 694756